Two weeks left to claim an Aspiration payment, PSNC reminds contractors


Share post:

The Pharmaceutical Services Negotiating Committee (PSNC) has reminded community pharmacy contractors that they have two weeks left to claim an Aspiration payment for the Pharmacy Quality Scheme (PQS) 2022/23.

The window for claiming the payment will close at 11.59pm on 4 November 2022.

“The Aspiration payment is optional; if contractors do not want to claim it, it will not impact on the contractor’s ability to claim a PQS payment during the declaration period. There is also no requirement to have claimed for a previous PQS to claim an Aspiration payment for PQS 2022/23,” said PSNC.

“If contractors wish to claim for an Aspiration payment, they should review the requirements of the PQS 2022/23, decide which domains they want to work towards meeting by the end of 31st March 2023 and declare this on the NHS Business Services Authority (NHSBSA) Manage Your Service (MYS) portal. Contractors should click on the ‘Pharmacy Quality Scheme’ tab on MYS to make a claim.”

Contractors will be paid their Aspiration payment on 1 December 2022.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...